Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from BioNTech

Vaccine maker’s £1bn UK investment to create ‘hundreds of high-skilled jobs’

BioNTech developed mRNA vaccines, and cancer immunotherapies notably used to tackle Covid-19.

Evening Standard · May 20, 2025

Why Is BioNTech Stock Trading Higher On Friday?

BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.

Benzinga · Dec 6, 2024

US inflation rises to 2.6% in October; Post Office closures put 2,000 jobs at risk – as it happened

Inflation figures closely watched by US Federal Reserve; core inflation holds steady at 3.3%

The Guardian - UK · Nov 13, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Mpox crisis: Why do African countries struggle to make or buy vaccines?

African countries produce less than 2 percent of the vaccines the continent needs, experts say.

Al Jazeera · Sep 12, 2024

World-first lung cancer vaccine trials launched across seven countries

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back

The Guardian - UK · Aug 23, 2024

Lung cancer vaccine: Breakthrough jab could improve survival rates

The vaccine, known as BNT116, utilises messenger RNA (mRNA), the same technology used in the Covid jab

The Independent UK · Aug 22, 2024

Lung cancer vaccine: How does it work?

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

The Independent UK · Aug 22, 2024

Read news from The Economist, FT, and more,
with one subscription

NHS patients in England to be offered trials for world-first cancer vaccine

Jab personalised for individual’s tumours hailed as ‘gamechanger’ amid high hopes of stopping disease returning

The Guardian - UK · May 30, 2024

The Fight Against Cancer Enters a New Phase

Breakthrough treatments hold promise for patients and investors.

Kiplinger · May 17, 2024

InstaDeep CEO Takes AI From Tunis To London

Karim Beguir launched the artificial intelligence start-up InstaDeep in Tunisia in 2014 with just two computers and $2,000.

International Business Times · Apr 21, 2024

Biontech Receives Notice Over Default On COVID Vaccine Royalties

BioNTech faces default notice from NIH over COVID vaccine royalties, raising concerns about ongoing pandemic response.

Breaking Through: My Life in Science by Katalin Karikó review – real-life lessons in chemistry

This vivid account of the Hungarian biochemist who endured decades of derision before pioneering Pfizer’s Covid vaccine is a tribute to her tenacity and self-belief

The Guardian - UK · Feb 11, 2024

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times · Dec 19, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Nov 27, 2023

UK will not return to Cameron era’s close ties with China, Sunak says

At summit to drum up foreign investment PM says he does not intend to change policy towards Beijing

The Independent UK · Oct 4, 2023

University of Pennsylvania slammed for celebrating Nobel prize of vaccine researcher it once demoted

University once reportedly discouraged Katalin Karikó from pursuing mRNA research that later helped create Covid vaccines

The Hindu · Oct 3, 2023

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

Fortune · Oct 2, 2023

The scientist whose research was key to developing the COVID vaccines was demoted, had her salary cut, and threatened with deportation. Today, she won the Nobel Prize

Katalin Karikó, now a vice-president at BioNTech, saw her research undermined for years before the 2005 breakthrough that led to the COVID-19 vaccine.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Oct 2, 2023

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Hindu · Oct 2, 2023

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

Zenger · Jul 30, 2023

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

The Independent UK · Jul 5, 2023

Up to 10,000 Britons could take part in cancer vaccine trials

Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company.

Zenger · Jun 26, 2023

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

StockNews.com · Jun 21, 2023

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

The Guardian - UK · Jun 20, 2023

‘Designing a vaccine that covers all cancers is hard’: biotech pioneer Lindy Durrant

The immunologist who runs Scancell is trialling novel treatments to attack tumours, as well as needle-free Covid jabs

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.